Nanopublication

< Home

ID

https://w3id.org/np/RAyys1DD9y9N9RUmgnB2d7CstMLsgMsYr14oyz-D7llu0

Formats

.trig | .trig.txt | .jelly | .jelly.txt | .jsonld | .jsonld.txt | .nq | .nq.txt | .xml | .xml.txt

Content

@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix drugbank: <https://identifiers.org/drugbank:> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix sub: <https://w3id.org/np/RAyys1DD9y9N9RUmgnB2d7CstMLsgMsYr14oyz-D7llu0/> .
@prefix this: <https://w3id.org/np/RAyys1DD9y9N9RUmgnB2d7CstMLsgMsYr14oyz-D7llu0> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  <doid:1040> a biolink:Disease .
  
  drugbank:DB09054 a biolink:Drug .
  
  sub:_1 a rdf:Statement;
    rdf:object <doid:1040>;
    rdf:predicate biolink:treats;
    rdf:subject drugbank:DB09054;
    rdfs:label "zydelig is a kinase inhibitor indicated for the treatment of patients with relapsed chronic lymphocytic leukemia";
    biolink:association_type biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    biolink:relation schema:TreatmentIndication .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1825-0097 .
}

sub:pubinfo {
  this: prov:generatedAtTime "2026-09-15T02:50:21.172560+00:00"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-1825-0097 .
  
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAwBGXXyMgFo7DHxMGvusAaaYLLvRpGCJLjv7YBau8VDMoQtWHYBustMSlGTRCfKlswA11r62pZy10wNp6Kdki6t7AaPfR3XaQjJzHUypgvs/CsS9JPwKT6oSob3DvneiREgAaDUrWpaGJfxAU4mE5AoCnejcUBpEGh/+3PJkllCOyWDvydN4BrZ0M6haa46Xy0g3iwPPfr35Pf91ZEUtfC88JYmUl3fIoPJRkAgmNydInyKxHU3KkQVffhFITJco701WUc5OOBD+Rgr5hOra3b/WDMiYanB+MpaxwX4JjbUlfdFVJsMokKMfEY3whkLJ3DymCfDR2GvsucjdFpwHTVQIDAQAB";
    npx:hasSignature "qVuNhwcNU68U5d/P4P7SX7oyyvvuNH4/LLQXZoPHECgexR1vfdslVhaodJlIhLmq5AVYsvig2244J7quOod3uuCquB+RcD21GKxmlDv+F0mb3HPei9D5eEOSvv2zACjIMbJ2r7/eZyT3ko7xM1ALlkr/VJRf8oFfZyCkk4nkwpuQQLJpsCT5/p48sr9Lwl1SYTn5ixYQe6UTvkaJMMZ1Z9BUAICUl7s/1sg5DAiV1ZXAlec32yR6YmbXMedt5M2onNQp9a3NhDoMYsSSD2a+VhOLCnjeZcyzmznUpYJSSUdyOHWRHRy/FDucHZY6fwhATUTbhSjWqfWlrYNXHw92aQ==";
    npx:hasSignatureTarget this:;
    npx:signedBy orcid:0000-0002-1825-0097 .
}